FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions
Abstract Background Chronic myeloid leukaemia (CML) is one of the most well characterised human malignancies. Most patients have a cytogenetically visible translocation between chromosomes 9 and 22 which generates the pathognomonic BCR::ABL1 fusion gene. The derivative chromosome 22 ('Philadelp...
Saved in:
Main Authors: | Philippa C. May (Author), Alistair G. Reid (Author), Mark E. Robinson (Author), Jamshid S. Khorashad (Author), Dragana Milojkovic (Author), Simone Claudiani (Author), Genomics England Research Consortium (Author), Fenella Willis (Author), Jane F. Apperley (Author), Andrew J. Innes (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting BCR-ABL1-positive leukaemias: a review article
by: Steven Leak, et al.
Published: (2023) -
Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment
by: Erin Clapper, et al.
Published: (2020) -
Cryptotanshinone enhances the efficacy of Bcr-Abl tyrosine kinase inhibitors via inhibiting STAT3 and eIF4E signalling pathways in chronic myeloid leukaemia
by: Rubin Cheng, et al.
Published: (2021) -
BCR/ABL positive thrombocythemia: a diagnostic dilemma
by: Lubna Zafar, et al.
Published: (2017) -
Prevalence, clinical and hematological profile and outcome of BCR-ABL1-like acute lymphoblastic leukaemia in Indian children: A prospective observational study
by: Sanjeev Khera, et al.
Published: (2024)